Breast Cancer Res. 2008;10 Suppl 2:L1-P95. Epub 2008 May 13.

Abstracts of the meeting of the Breast Cancer Campaign. London, United Kingdom. May 13, 2008.

[No authors listed]

Free full text

Supplemental Content

Joint winter meeting of the British Association for Cancer Research, the Cancer Research Campaign and the Imperial Cancer Research Fund. London, December 3-4, 1987. Abstracts. [Br J Cancer. 1988]
Joint winter meeting of the British Association for Cancer Research, the Cancer Research Campaign and the Imperial Cancer Research Fund. London, December 3-4, 1987. Abstracts.
. Br J Cancer. 1988 Feb; 57(2):219-232.
Abstracts of Breast Cancer Research 2010. London, United Kingdom. May 18, 2010. [Breast Cancer Res. 2010]
Abstracts of Breast Cancer Research 2010. London, United Kingdom. May 18, 2010.
. Breast Cancer Res. 2010; 12 Suppl 1:L1-3, O1-6, P1-59.
Symposium Mammographicum 2000, Meeting Abstracts, York, United Kingdom, 4 - 6 October 2000. [Breast Cancer Res. 2000]
Symposium Mammographicum 2000, Meeting Abstracts, York, United Kingdom, 4 - 6 October 2000.
. Breast Cancer Res. 2000 Oct 10; 2 Suppl 2:A1-70. Epub 2000 Oct 10.
Review Emerging drugs in metastatic breast cancer. [Expert Opin Emerg Drugs. 2009]
Review Emerging drugs in metastatic breast cancer.
Dizdar O, Altundag K. Expert Opin Emerg Drugs. 2009 Mar; 14(1):85-98.
Review Breast cancer. Part 1: Awareness and common benign diseases. [Br J Nurs. 2008]
Review Breast cancer. Part 1: Awareness and common benign diseases.
Harmer V. Br J Nurs. 2008 Aug 14-Sep 10; 17(15):950-5.

Abstracts of the meeting of the Breast Cancer Campaign. London, United Kingdom. ...
Abstracts of the meeting of the Breast Cancer Campaign. London, United Kingdom. May 13, 2008.
Breast Cancer Res. 2008 ;10 Suppl 2:L1-P95. Epub 2008 May 13 .

PubMed
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
JAMA. 2006 Jun 7 ;295(21):2492-502.

PubMed
EGF receptor transactivation by G-protein-coupled receptors requires metalloprot...
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.
Nature. 1999 Dec 23-30 ;402(6764):884-8.

PubMed
A phase II trial of imatinib mesylate monotherapy in patients with metastatic br...
A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer.
Breast Cancer Res Treat. 2005 Mar ;90(2):157-63.

PubMed
Cancer statistics, 2003.
Cancer statistics, 2003.
CA Cancer J Clin. 2003 Jan-Feb ;53(1):5-26.

PubMed

Your browsing activity is empty.

Activity recording is turned off.